BIO Presents Dr. Ganesh Kishore New Award for Leadership and Legacy in Industrial Biotechnology
Washington, D.C. (April 20, 2016) The Biotechnology Innovation Organization (BIO) presented Dr. Ganesh Kishore, CEO, MLSCFI and co-Managing Partner, Spruce Capital Partners, the first annual BIO Leadership and Legacy Award today during BIO’s 13th Annual World Congress on Industrial Biotechnology. The new award was created to honor an individual who has shown exemplary leadership and who has dedicated a significant portion of their career to advancing industrial biotechnology and growing the biobased economy. The world’s largest industrial biotechnology event was held April 17-20, 2016 at the San Diego Convention Center in San Diego, CA.
“BIO is pleased to announce Dr. Ganesh Kishore as winner of the first annual BIO Leadership and Legacy Award in Industrial Biotechnology,” said Brent Erickson, executive vice president for BIO’s Industrial & Environmental Section. “The BIO Leadership and Legacy Award honors those who have left a lasting impression on the industry and whose legacy will endure the test of time. This award is dedicated to all who have left and continue to leave their mark in the field of industrial biotechnology.”
Dr. Kishore has a distinguished track record of accomplishments in industrial and agriculture biotechnology research and development and business.
He was a senior executive and innovation leader at Monsanto and DuPont. He has co-founded three successful entities since 2002, across the spectrum of industrial biosciences, agriculture, and environment.
In 2007, Dr. Kidhore left DuPont where he was Chief Biotechnology Officer to join Malaysian Life Science Capital Fund (MLSCF) as its CEO and later cofounded Spruce Capital Partners in 2013.
He serves on the board of three publicly listed entities, three privately held companies and the Advisory Board of Washington University. Dr. Kishore holds seventy issued patents and has sixty technical publications.
In 2015, Dr. Kishore was named to the WorldVIEW 100 list as one of the most influential people in biotech today.
All programs at the World Congress on Industrial Biotechnology were open to attendance by members of the media. Complimentary media registration was available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.
For more information on the conference, please visit http://go.bio.org/WorldCongress2016.html. For assistance, please contact worldcongress@bio.org.
About BIO
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org.
Upcoming BIO Events